Dr Judith M Kernodle, MD in Dorset, VT - Psychiatry & Neurology

Dr Judith M Kernodle, MD is a Psychiatry & Neurology - Psychiatry physician based in Dorset, Vermont. Dr Judith M Kernodle is licensed to practice in New Jersey (license number #25MAD6309000) and her current practice location is 2097 Route 30, Dorset, Vermont. She can be reached at her office (for appointments etc.) via phone at (201) 819-6181.

NPI number for Dr Judith M Kernodle is 1043373400 and her current mailing address is 2097 Route 30, Dorset, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043373400.

Contact Information

	Dr Judith M Kernodle, MD
	2097 Route 30, Dorset, VT 05251-9411
	(201) 819-6181
	Not Available

Physician's Profile

Full Name	Dr Judith M Kernodle
Gender	Female
Speciality	Psychiatry & Neurology - Psychiatry
Location	2097 Route 30, Dorset, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1043373400
Provider Enumeration Date: 12/18/2006
Last Update Date: 09/16/2021

Medical Identifiers

Medical identifiers for Dr Judith M Kernodle such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043373400	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	#25MAD6309000 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Judith M Kernodle is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Judith M Kernodle, MD 2097 Route 30, Dorset, VT 05251-9411 Ph: (201) 819-6181	Dr Judith M Kernodle, MD 2097 Route 30, Dorset, VT 05251-9411 Ph: (201) 819-6181

News Archive

New technology to diagnose influenza quickly

A new technology is showing promise as the basis for a much-needed home test to diagnose influenza quickly, before the window for taking antiviral drugs slams shut and sick people spread the virus to others, scientists reported here today. In a presentation at the 246th National Meeting & Exposition of the American Chemical Society (ACS), they described how it also could determine the specific strain of flu virus and help select the most effective drug for treatment.

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

The South African Government's policy to reduce the risk of mother to child transmission of HIV, remains unchanged.

Black women in the US less likely to access preventative cancer treatments

A report from the University of Pennsylvania School of Medicine in Philadelphia says that black women in the US with a family history of breast or ovarian cancer, are far less likely to seek genetic counselling and possible testing than their white counterparts, and although the reasons for the disparity are not clear, it is suspected that mistrust of both the medical system and advice from primary physicians may be factors.

New work on Akt's role in cancer stem cell biology

The protein kinase Akt is a key regulator of cell growth, proliferation, metabolism, survival, and death. New work on Akt's role in cancer stem cell biology from the lab of senior author Honglin Zhou, MD, PhD and Weihua Li, co-first author, both from the Center for Resuscitation Sciences, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, and Xiaowei Xu, Department of Pathology and Laboratory Medicine, appears in Molecular Cell.

Sequencing of whole prostate cancer genomes - an historic development

Today's announcement regarding the sequencing of whole prostate cancer genomes is an historic development in the fight against prostate cancer. The ability to sequence whole genomes will spare some patients from unnecessary treatments and side effects while eliminating an estimated $1.5 billion that is spent each year on overtreatment. The complete research findings will be published in the February 10 issue of Nature.

Dr Judith M Kernodle, MD - Psychiatry & Neurology in Dorset, VT